Ticker | $ Bought |
---|---|
bristol-myers squibb co | 19,821,800 |
dexcom inc | 10,585,000 |
anteris technologies global | 4,695,600 |
verona pharma plc | 4,444,300 |
akero therapeutics inc | 3,744,400 |
ultragenyx pharmaceutical inc | 2,969,220 |
moonlake immunotherapeutics | 1,758,150 |
denali therapeutics inc | 1,359,500 |
Ticker | % Inc. |
---|---|
glaukos corp | 639 |
insmed inc | 201 |
alnylam pharmaceuticals inc | 183 |
elevance health inc | 111 |
cooper cos inc | 105 |
molina healthcare inc | 99.42 |
astrana health inc | 87.5 |
syndax pharmaceuticals inc | 86.64 |
Ticker | % Reduced |
---|---|
inspire med sys inc | -89.34 |
merck & co. inc | -88.11 |
apellis pharmaceuticals inc | -85.56 |
immunovant inc | -82.12 |
the cigna group | -64.02 |
ionis pharmaceuticals inc | -61.88 |
becton dickinson & co | -60.33 |
biogen inc | -59.98 |
Ticker | $ Sold |
---|---|
intra-cellular therapies inc | -14,699,500 |
igm biosciences inc | -770,251 |
pliant therapeutics inc | -1,531,010 |
novo-nordisk a s | -4,301,000 |
transmedics group inc | -2,369,300 |
universal hlth svcs inc | -5,544,080 |
stryker corporation | -8,101,120 |
charles riv labs intl inc | -2,741,310 |
Rhenman & Partners Asset Management AB has about 97.4% of it's holdings in Healthcare sector.
Sector | % |
---|---|
Healthcare | 97.4 |
Others | 2.5 |
Rhenman & Partners Asset Management AB has about 73.2% of it's portfolio invested in the large-cap and mega-cap stocks.
Category | % |
---|---|
LARGE-CAP | 61.4 |
MID-CAP | 18.5 |
MEGA-CAP | 11.8 |
SMALL-CAP | 6.6 |
UNALLOCATED | 1.6 |
About 79.4% of the stocks held by Rhenman & Partners Asset Management AB either belong to S&P 500 or RUSSELL 2000 index.
Index | % |
---|---|
S&P 500 | 57.6 |
RUSSELL 2000 | 21.8 |
Others | 20.5 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
Rhenman & Partners Asset Management AB has 94 stocks in it's portfolio. About 34.3% of the portfolio is in top 10 stocks. PRCT proved to be the most loss making stock for the portfolio. ALHC was the most profitable stock for Rhenman & Partners Asset Management AB last quarter.
Last Reported on: 14 May, 2025Ticker | Namesorted descending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
---|---|---|---|---|---|---|---|---|
UNH | united health group inc | 4.66 | 77,430 | 40,554,000 | added | 27.92 | ||
Historical Trend of UNITED HEALTH GROUP INC Position Held By Rhenman & Partners Asset Management ABWhat % of Portfolio is UNH?:Number of UNH shares held:Change in No. of Shares Held: | ||||||||
LLY | lilly eli & co | 3.96 | 41,750 | 34,481,700 | reduced | -8.14 | ||
VRTX | vertex pharmaceuticals inc | 3.72 | 66,750 | 32,361,700 | added | 33.5 | ||
MCK | mckesson corp | 3.65 | 47,217 | 31,776,600 | added | 38.4 | ||
BSX | boston scientific corp | 3.48 | 300,000 | 30,264,000 | reduced | -32.43 | ||
GKOS | glaukos corp | 3.05 | 270,000 | 26,573,400 | added | 639 | ||
GILD | gilead sciences inc | 3.01 | 233,500 | 26,163,700 | reduced | -8.61 | ||
PRCT | procept biorobotics corp | 3.00 | 448,000 | 26,100,500 | added | 6.58 | ||
ISRG | intuitive surgical inc | 2.93 | 51,500 | 25,506,400 | reduced | -19.53 | ||
ALHC | alignment healthcare inc | 2.86 | 1,337,280 | 24,900,200 | reduced | -24.07 | ||
MDT | medtronic plc | 2.63 | 255,000 | 22,914,300 | reduced | -5.38 | ||
MOH | molina healthcare inc | 2.58 | 68,200 | 22,464,400 | added | 99.42 | ||
ELV | elevance health inc | 2.45 | 48,950 | 21,291,300 | added | 111 | ||
REGN | regeneron pharmaceuticals | 2.32 | 31,750 | 20,136,800 | reduced | -26.94 | ||
COO | cooper cos inc | 2.29 | 236,000 | 19,906,600 | added | 105 | ||
BMY | bristol-myers squibb co | 2.28 | 325,000 | 19,821,800 | new | |||
NTRA | natera inc | 2.25 | 138,500 | 19,585,300 | added | 12.23 | ||
EXAS | exact sciences corp | 2.19 | 440,000 | 19,047,600 | reduced | -6.58 | ||
BMRN | biomarin pharmaceutical inc | 2.15 | 265,000 | 18,732,800 | added | 5.74 | ||
ABBV | abbvie inc | 2.13 | 88,650 | 18,573,900 | reduced | -28.59 | ||